Purchase Order W81XWH20P0190

This firm fixed price purchase order was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Life Technologies Corporation for $35,692.80. The contract calls for Life Technologies to deliver 80 units of heat inactivated fetal bovine serum with lot number 2661794P to the NIH Clinical Center in Bethesda, Maryland. The serum will support ongoing cell culture work and clinical research being performed by the Laboratory of Immunoregulation's HIV...

<p>The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $121,618.00 firm fixed price purchase order to Sanofi Pasteur Biologics, LLC, a for-profit foreign-owned organization, for WETVAX testing services. The contract was awarded on May 11, 2017 with a completion date of September 30, 2017. The place of performance is Cambridge, MA 02139, USA. This contract was not set aside for any specific socioeconomic program.</p>

This firm-fixed-price purchase order was awarded by the U.S. Department of Agriculture's Veterinary Services agency to Life Technologies Corporation, doing business as Thermo Fisher Scientific, for the delivery of BOVIGAM test kits. The contract has a ceiling value of $81,648.00 and a completion date of September 15, 2025. The awardee is a for-profit manufacturer of scientific instruments, reagents, and consumables that has a history of providing specialized biotechnology products and services...

This firm fixed-price purchase order was awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Battelle Memorial Institute, doing business as Battelle, for $3,977,119. The objective is to explore immune correlates of protection in rhesus macaques administered various SARS-CoV-2 vaccine candidates designed by Moderna, Novavax, Janssen and Sanofi Pasteur. Battelle will conduct the study under an approved quality management plan...

The USDA APHIS Marketing and Regulatory Programs Business Services awarded a $13,500 firm fixed price purchase order to Colorado Serum Company, doing business as Colorado Serum Co, to deliver 15-100mL bottles of RCN virus vectored vaccine. Place of performance will be in Denver, Colorado, with work occurring between July 1-31, 2023. As part of its mission to protect animal health, the USDA APHIS likely requires this Rift Valley fever vaccine to support its livestock disease prevention...

This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Epivax Inc., a for-profit, woman-owned small business, to conduct research and development related to predicting the immunogenicity of the Bordetella pertussis bacteria and improving T cell responses in vaccines. The contract has a potential value of $200,692.00 and a completion date of August 14, 2020. No set-aside designation was used for...

This is a firm fixed price BPA call awarded to The Binding Site, Inc. by the Department of Veterans Affairs (VA) with a ceiling value of $258,968.51 and an ultimate completion date of June 14, 2024. The contract is for the provision of EO14042 - COVID-19 vaccine mandate information, as well as KAPPA LAMBA and HEVY LITE testing kits. The Binding Site, a for-profit medical diagnostics company, provides specialized laboratory equipment, reagents, supplies, and testing services to support clinical...

<p>The Department of Agriculture Animal and Plant Health Inspection Service Veterinary Services awarded a $58,131.60 firm fixed price delivery order to Vmrd Inc. of Pullman, Washington for antibody test kits. The delivery order, which must be completed by June 20, 2022, has no set-aside designation and was awarded on June 15, 2022 to support the agency's animal health programs. Vmrd Inc. will deliver the antibody test kits as a prime contractor to the funding agency.</p>

The National Institute of Allergy and Infectious Diseases (NIAID) awarded Battelle Memorial Institute a $20.4 million delivery order contract on September 15, 2003, for the development of a Bacillus anthracis spore challenge model and performance studies using the rPA (recombinant protective antigen) vaccine. The contract, which operated on a cost-plus-fixed-fee basis through September 30, 2012, was issued with no set-aside designation, reflecting open competition for this specialized scientific...

This cost-plus-fixed-fee contract was awarded by the Centers for Disease Control and Prevention to Vitalant Research Institute to characterize the seroprevalence of SARS-CoV-2 antibodies in the U.S. population through May 2024. The $46.4 million contract expands Vitalant's ongoing work under the National SARS-CoV-2 Seroincidence Studies in Blood Donors contract to provide additional longitudinal data on antibody stability and reinfection risk through testing approximately 130,000 blood donors....